A systematic review of effectiveness of BNT162b2 mRNA and ChAdOx1 adenoviral vector COVID-19 vaccines in the general population.

Chinonyerem Ogadi IheanachoUchenna I H EzeEmmanuel A Adida

Published in: Bulletin of the National Research Centre (2021)

BNT162 and ChAdOx1 vaccines were associated with equivalent and high effectiveness which increased with time and a second dose in the general population. This encourages continued practice of other preventive measures, particularly during the first week of vaccination, and reinforces the need for a second dose.

Keyphrases

randomized controlled trial
systematic review
coronavirus disease
sars cov
healthcare
primary care
clinical trial
quality improvement